Ysios Capital | AELIX Therapeutics
< href=http://rxbuywithoutprescriptiononline.net/propecia.html>Propecia no prescription < href=http://rxbuywithoutprescriptiononline.org/lasix.html>lasix buy Sertraline online < href=http://rxnoprescriptionbuyonlinerx.net>Accutane without prescription buy trazodone online buy Zyban without prescription < href=http://rxbuyonlinewithoutprescription.net/zetia.html>zetia without prescription < href=http://rxbuywithoutprescriptiononline.net/clomid.html>Clomid Without Prescription < href=http://rxbuywithoutprescriptiononline.org/ventolin.html>buy ventolin < href=http://rxnoprescriptionbuyonline.com/strattera.html>buy Strattera < href=http://rxbuyonlinewithoutprescriptionrx.net/valtrex.html>buy Valtrex online < href=http://rxbuywithoutprescriptiononline.net/zithromax.html>buy Zithromax without prescription
portfolio

AELIX Therapeutics

Aelix Therapeutics develops therapeutic vaccines and immunotherapies to treat HIV infection. The company is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV.
 
 
Aelix Therapeutics portfolio Ysios Capital
 

Details
AELIX Therapeutics
Parc Científic de Barcelona
Baldiri i Reixac 4-8
Barcelona, 08028
Spain
www.aelixtherapeutics.com

 
AELIX Therapeutics news

18.10.17
AELIX Therapeutics appoints Dr. Thomas Hecht as Chairman of the Board of Directors

06.09.17
AELIX Therapeutics enrolls first patient in company’s initial therapeutic HIV vaccine clinical trial

05.04.17
Aelix Therapeutics appoints Dr. Ian McGowan as Chief Medical Officer

Read more
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. For more information on cookies check http://www.ysioscapital.com/legal-notice/ I agree